Sigma-Tau Pharmaceuticals, Inc.
Records under this name other than patents Sigma-Tau Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Sigma-Tau Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,333,894 | Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients Formerly held Term ended Term ended Nov 26, 2024 · USPTO record | Term ended | Term ended Nov 26, 2024 | USPTO record |
| US 7,011,977 | Quantification of carnitine levels in dialysis patients Formerly held Term ended Term ended Oct 3, 2019 · USPTO record | Term ended | Term ended Oct 3, 2019 | USPTO record |
| US 4,839,159 | Topical L-carnitine composition Term ended Term ended no later than Jun 13, 2009 · Low confidence | Term ended | Term ended no later than Jun 13, 2009 | Low confidence |
| US 5,686,491 | Infant formula Term ended Term ended no later than Nov 11, 2017 · Low confidence | Term ended | Term ended no later than Nov 11, 2017 | Low confidence |
| US 5,958,886 | Carnitine-containing peptides and a method for using the same Term ended Term ended no later than Sep 28, 2019 · Low confidence | Term ended | Term ended no later than Sep 28, 2019 | Low confidence |